Monthly Archives: April 2013

Unhealthy Prognosis for Venture-Backed Diagnostics
April 26, 2013

Personalized medicine and diagnostics are undoubtedly critical to the delivery of better healthcare in the future: getting the right drug to the right patient at the right time.  In theory, these therapy-guiding diagnostics should reduce the cost of healthcare while


On-Q-ity, a Cancer Diagnostic Company: R.I.P.
April 10, 2013

Not every deal is a winner, and unfortunately On-Q-ity wasn’t.  After a few years of hammering away at its diagnostic business case, the board decided to wind the company down back in November and we are just completing the sale